V

ValenzaBio

6 employees

ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical
Biopharma

Date founded

2019

Funding rounds raised

Total raised

$79M

from 3 investors over 3 rounds

V

ValenzaBio raised $79M on April 8, 2021

Investors: Ikarian Capital LLC, Pierre Fabre and Surveyor Capital

FAQ